Neurological complications of neurofibromatosis type 1 in adulthood

Brain

Volumn 122, Issue 3, 1999, Pages 473-481

  Creange A ^a   Zeller, J ^a   Rostaing Rigattieri, S ^a   Brugieres P ^a   Degos, J D ^a   Revuz, J ^a   Wolkenstein, P ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Adulthood; Neurofibromatosis type 1; Neurological complications

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN AQUEDUCT STENOSIS; CLINICAL FEATURE; EPILEPSY; FACIAL NERVE PARALYSIS; FEMALE; GLIOMA; HEADACHE; HUMAN; HYDROCEPHALUS; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MORBIDITY; NERVE SHEATH TUMOR; NEUROFIBROMA; NEUROFIBROMATOSIS; NEUROLOGICAL COMPLICATION; PAIN; POLYNEUROPATHY; PRIORITY JOURNAL; RADICULOPATHY; RADIOLOGY; SCHOOL CHILD; SPINAL CORD COMPRESSION; STROKE; VISUAL SYSTEM; WHITE MATTER;

ADOLESCENT; ADULT; AGED; AGING; BRAIN NEOPLASMS; CHILD; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCEPHALUS; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 1; OPTIC NERVE NEOPLASMS; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; SPINAL CORD COMPRESSION; TREATMENT OUTCOME;

EID: 0343856490     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.3.473     Document Type: Article

References (34)

1. Alshail E, Rutka JT, Becker LE, Hoffman HJ. Optic chiasmatic-hypothalamic glioma. [Review]. Brain Pathol 1997; 7: 799-806.
2. Bilaniuk LT, Molloy PT, Zimmerman RA, Phillips PC, Vaughan SN, Liu GT, et al. Neurofibromatosis type 1: brain stem tumours. Neuroradiology 1997; 39: 642-53.
3. Boydston WR, Sanford RA, Muhlbauer MS, Kun LE, Kirk E, Dohau FC Jr, et al. Gliomas of the tectum and periaqueductal region of the mesencephalon. Pediatr Neurosurg 1992; 17: 234-8.
4. Buenger K, Porter NC, Dozier SE, Wagner RF Jr. Localized multiple neurilemmomas of the lower extremity. [Review]. Cutis 1993; 51: 36-8.
5. Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations [published erratum appears in Cell 1990; 62: following 608]. Cell 1990; 62: 193-201.
6. Clementi M, Barbujani C, Turolla L, Tenconi R. Neurofibromatosis 1: a maximum likelihood estimation of mutation rate. Hum Genet 1990; 84: 116-8.
7. Colman SD, Williams CA, Wallace MR. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 1995; 11: 90-2.
8. DiMario FJ Jr, Ramsby G, Greenstein R, Langshur S, Dunham B. Neurofibromatosis type 1: magnetic resonance imaging findings. J Child Neurol 1993; 8: 32-9.
9. Friedman JM, Birch PH. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 1997; 70: 138-43.
10. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2 [see comments]. [Review]. JAMA 1997; 278: 51-7. Comment in: JAMA 1997; 278: 1493-4.
11. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2 [see comments]. [Review]. JAMA 1997; 278: 51-7. Comment in: JAMA 1997; 278: 1493-4.
12. Hughes RAC. Neurological complications of neurofibromatosis 1. In: Huson SM, Hughes RAC, editors. The neurofibromatoses: a pathogenetic and clinical overview. London: Chapman and Hall; 1994. p. 204-32.
13. Huson SM. Neurofibromatosis 1: a clinical and genetic overview. In: Huson SM, Hughes RAC, editors. The neurofibromatoses: a pathogenetic and clinical overview. London: Chapman and Hall; 1994. p. 160-203.
14. Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis: a clinical and population study in south east Wales. Brain 1988; 111: 1355-81.
15. Huson SM, Compston DA, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate and effect of parental transmission on severity. J Med Genet 1989a; 26: 704-11.
16. Huson SM, Compston DA, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in South East Wales. II. Guidelines for genetic counselling. [Review]. J Med Genet 1989b; 26: 712-21.
17. Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 1997; 41: 143-9.
18. MacCollin M, Woodfin W, Kronn D, Short MP. Schwannomatosis: a clinical and pathologic study [see comments]. Neurology 1996; 46: 1072-9. Comment in: Neurology 1997; 48: 787-8.
19. MacCollin M, Woodfin W, Kronn D, Short MP. Schwannomatosis: a clinical and pathologic study [see comments]. Neurology 1996; 46: 1072-9. Comment in: Neurology 1997; 48: 787-8.
20. National Institutes of Health Consensus Development Conference. Neurofibromatosis. Conference statement. Arch Neurol 1988; 45: 575-8.
21. Pollack IF, Shultz B, Mulvihill JJ. The management of brainstem gliomas in patients with neurofibromatosis 1. [Review]. Neurology 1996; 46: 1652-60.
22. Radhakrishnan K, Kak VK, Sridharan R, Chopra JS. Adult aqueductal stenosis with Recklinghausen's neurofibromatosis. Surg Neurol 1981; 16: 262-5.
23. Riccardi VM. Neurofibromatosis: past, present, and future. N Engl J Med 1991; 324: 1283-5.
24. Riccardi VM, editor. Neurofibromatosis: phenotype, natural history, and pathogenesis. 2nd ed. Baltimore: Johns Hopkins University Press; 1992.
25. Senveli E, Altinörs N, Kars Z, Arda N, Turker A, Cinar N, et al. Association of von Recklinghausen's neurofibromatosis and aqueduct stenosis [see comments]. [Review]. Neurosurgery 1989; 24: 99-101. Comment in: Neurosurgery 1989; 25: 318-9.
26. Senveli E, Altinörs N, Kars Z, Arda N, Turker A, Cinar N, et al. Association of von Recklinghausen's neurofibromatosis and aqueduct stenosis [see comments]. [Review]. Neurosurgery 1989; 24: 99-101. Comment in: Neurosurgery 1989; 25: 318-9.
27. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992; 267: 64-9.
28. Tonsgard JH, Kwak SM, Short MP, Dachman AH. CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions. Neurology 1998; 50: 1755-60.
29. Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, et al. Deletions and translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990; 62: 187-92.
30. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients [published erratum appears in Science 1990; 250: 1749]. Science 1990; 249: 181-6.
31. Waters WE, O'Connor PJ. Prevalence of migraine. J Neurol Neurosurg Psychiatry 1975; 38: 613-6.
32. Wolkenstein P, Frèche B, Zeller J, Revuz J. Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients [see comments]. Arch Dermatol 1996; 132: 1333-6. Comment in: Arch Dermatol 1997; 133: 655-6.
33. Wolkenstein P, Frèche B, Zeller J, Revuz J. Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients [see comments]. Arch Dermatol 1996; 132: 1333-6. Comment in: Arch Dermatol 1997; 133: 655-6.
34. Zoller M, Rembeck B, Akesson HO, Angervall L. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden. Acta Derm Venereol 1995; 75: 136-40.